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Percutaneous Closure of a Left Ventricular
Pseudoaneurysm After Sapien XT Transapical
Transcatheter Aortic Valve Replacement
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(aortic valve area: 0.6 cm2, mean gradient: 60 mm Hg,
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e38open aortic valve replacement (Society of Thoracic Surgeons
class 10.6) due to a history of chronic hepatitis on azathio-
prine, coronary artery disease, atrial fibrillation, multiple
falls with hip and clavicular fractures, and frailty (body mass
index: 15.6 kg/m2). The procedure was performed transapi-
cally due to poor peripheral access. She underwent a left
mini thoracotomy and a 23-mm Sapien XT prosthesis
(Edwards Lifesciences, Irvine, California) was inserted via
the Ascendra 2 delivery system (Edwards Lifesciences).
Two perpendicular, pledgeted horizontal mattress sutures
were placed in the muscular portion of the anterior left
ventricular (LV) apex. The pledgeted sutures were tied
down under rapid ventricular pacing at completion of the
procedure and after removal of the sheath. There was
satisfactory hemostasis, a third anchoring suture was placed
as a precaution, and chest closure was performed. The
patient was discharged on post-operative day 6.
Two weeks after the procedure, the patient presented to
an outside hospital with left-sided abdominal pain and
bilious vomiting. Computed tomography demonstrated a
small bowel obstruction. There was an incidental finding of
a 19  31  27 mm contrast-filled structure adjacent to the
LV, and she was transferred for further management. A
transthoracic echocardiogram with contrast confirmed the
presence of an LV pseudoaneurysm with a 3.5-mm neck
(Fig. 1A) (Online Video 1). LV pseudoaneurysm is a
recognized but rare complication and has implications for
the delivery of other devices through the LV apex (1–3).
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was made to proceed with percutaneous closure of the pseu-
doaneurysm using a 6-mm Amplatzer muscular Ventricular
Septal Defect Occluder (St. Jude Medical Inc., St. Paul,
Minnesota) via a retrograde approach from the right femoral
artery. The procedure was performed in a hybrid operating
room with fluoroscopic and transesophageal echocardiographic
guidance (Fig. 1B) (Online Video 2).
The tract was crossed with a 6-F multipurpose diagnostic
catheter and a 0.035-inch Terumo Glidewire (Terumo
Medical Corp., Somerset, New Jersey). A complex struc-
ture, consisting of a small upper pouch communicating with
a lower, larger pouch was seen on selective angiography
(Fig. 1C). A 0.035-inch exchange length Amplatz Extra
Stiff wire (Cook Medical, Bloomington, Indiana) was ad-
vanced through the multipurpose diagnostic catheter and
used to exchange for an 8-F multipurpose guide catheter.
The muscular Ventricular Septal Defect Occluder device
was deployed and released (Fig. 1D). Final ventriculography
showed no flow into the pseudoaneurysm and a stable
muscular Ventricular Septal Defect Occluder closure device
in the wall of the LV (Fig. 1E) (Online Video 3). The
patient tolerated the procedure and was discharged 5 days
after procedure once the small bowel obstruction resolved.
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